Table of Contents
What changed
Revenue rose 11.3% to NZ$1b, crossing the billion-dollar line for the first time. Trading profit before tax lifted 21.4% to NZ$49.4m and NPAT attributable grew 33.6% to NZ$33.2m. The final dividend was lifted to 47.0 cents per share (+17.5%); combined with the unchanged 15.0 cps interim, full-year dividends are 62.0 cps against 55.0 cps in FY21.
Balance-sheet composition shifted materially even though the totals moved little. Inventories fell 16.1% to NZ$137.0m, implying inventory days compressed to roughly 49.9 from 66.2. Total assets rose only 2.3% to NZ$458.2m, but equity expanded 15.8% to NZ$307.8m as retained earnings accumulated and cash fell to NZ$11.8m from NZ$14.7m. Full-year operating cash flow is not in the supplied extracts (prior year: NZ$28.9m; HY22 was already negative NZ$1.5m).
What matters
- NPAT grew faster than PBT (33.6% vs 21.4%). The cleaner operating read is PBT +21.4%. The supplied calculations flag this as a tax/below-the-line effect and note no discontinued operation was disclosed to explain the gap; investors should treat the headline NPAT growth rate as partly a below-PBT artefact rather than pure operating leverage.
- Inventory compression, not just trading strength, is shaping this result. For an automotive retailer, a 16.1% fall in stock while revenue grows 11.3% is unusual and consistent with sector-wide new-vehicle supply constraints rather than deliberate discipline. That lifts sell-through optics but limits the read-across on underlying demand, and it risks a working-capital reversal as supply normalises.
- Cash balance and cash-flow disclosure. Cash declined NZ$2.9m despite strong reported profit, and the FY22 operating cash flow line is not in the provided extract. Given HY22 OCF was negative NZ$1.5m, the shape of second-half cash generation is central to the quality of this result and cannot be confirmed from what is supplied.
Expectations
No management targets, forward-order book, or explicit FY23 guidance were disclosed in the extracts, so the release cannot be benchmarked against a stated plan. Seasonality context from HY22 shows the year was modestly first-half weighted: HY22 carried 53.4% of full-year revenue and 54.5% of full-year NPAT, so implied H2 revenue was NZ$467.2m and implied H2 NPAT NZ$15.1m — a softer second half than the first on both lines. That shape is consistent with tightening vehicle supply through the year rather than accelerating demand.
Quality of result
The operating story looks real but not fully durable. PBT growth of 21.4% on 11.3% revenue growth points to genuine operating leverage, and ROE improving to 10.8% from 9.3% supports that. However, several features temper the read:
- Headline NPAT growth of 33.6% overstates the operating uplift because of the sub-PBT movement flagged in the calculations.
- The inventory-days improvement to ~49.9 days is more likely supply-constrained than structural; in auto retail, unusually low stock tends to normalise and absorb cash when OEM supply recovers.
- Cash holdings fell despite reported profit growth and a NZ$26.4m inventory release, and the FY22 operating cash flow figure is not in the supplied material. HY22 OCF of −NZ$1.5m means the full-year cash conversion cannot be confirmed from this release and is a live concern.
- Management uses non-GAAP "Trading Profit" labels without a full reconciliation to statutory measures in the extracts provided.
Unresolved
- What was FY22 operating cash flow, and how did cash convert versus NZ$33.2m NPAT given the NZ$26.4m inventory release?
- What explains NPAT growing 12.3 percentage points faster than PBT — minority interest changes, tax timing, or another below-the-line item?
- Is the inventory drop deliberate discipline or a function of new-vehicle and truck/tractor supply constraints, and how much of gross margin was helped by reduced discounting in a supply-tight market?
- No gross margin, segment split (motor vehicles vs heavy trucks vs tractors), borrowings, or net-debt figures were disclosed in the extract, leaving leverage direction and mix-margin quality unassessable.
- No FY23 guidance, forward order book, or concentration disclosure was supplied.
This briefing cannot assess cash conversion, gross-margin movement, segment mix, or leverage because the underlying cash flow statement, margin detail, segment disclosure, and borrowings data were not present in the supplied extracts.
Key metrics
| Metric | FY22 | FY22 | Change |
|---|---|---|---|
| Revenue | $1b | $901.2m | +11.3% ↑ |
| Net profit after tax | $33.2m | $24.8m | +33.6% ↑ |
| Net cash inflow from operating activities | — | $28.9m | — |
| Final dividend per share | 47.0c | 47.0c | flat |
| Profit before tax | $49.4m | $40.7m | +21.4% ↑ |
| Cash and cash equivalents | $11.8m | $14.7m | -19.6% ↓ |
| Total assets | $458.2m | $447.7m | +2.3% ↑ |
Analytical metrics
| Metric | FY22 | FY22 | Context |
|---|---|---|---|
| PBT growth | +21.4% | — | cleaner earnings measure |
| Effective tax rate | 28.3% | 27.5% | — |
| Inventory days | 49.9 | 66.2 | -16.3 days |
| Payout ratio vs NPAT | 46.3% | — | — |
| Annual payout ratio vs EPS | 61.1% | — | final plus interim dividends |
| ROE (annualised) | 10.8% | 9.3% | Strengthening |
| HY22 share of FY22 revenue | 53.4% | — | Other half was 46.6% |
| HY22 share of FY22 NPAT | 54.5% | — | Other half was 45.5% |
| Profit from continuing operations | $33.3m | $27.9m | +$5.4m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.